HWKN
Hawkins, Inc.
$132.02
▲ +3.12%
+$3.99
NYSE · Basic Materials · Specialty Chemicals
· price updated 9h ago
Hawkins, Inc.
HWKN · NYSE · Basic Materials · Specialty Chemicals · price updated 9h ago
$132.02
▲ +3.12% · +$3.99 today
AI research · $132.02
HWKN, researched
Earnings miss overshadows record revenue
refreshed Jul 31
price position
Where HWKN sits now
52-week range
Low$117.98
High$186.15
Today $132.02
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$8.0M
Total debt$257.7M
Net cash after debt$-249.7M
Valuation
What the market charges
Forward P/E
Price against expected earnings
Needs attention · 147% above Sector avg
30.63x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
2.42x
Price / FCF
Price against free cash generation
Reasonable · Between 20x and 35x free cash flow
29.15x
EV / EBITDA
Operating value including debt
Reasonable · Between 12x and 22x EBITDA
16.91x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Reasonable · An 8% to 15% return on capital
10.6%
ROE
Profit generated from shareholder equity
Middle ground · Roughly in line with sector
15.6%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.47x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
2.27x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How HWKN compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $2.67B | 33.1 | +9.3% | 50 |
 | $98.74B | 11.8 | +25.2% | 83 |
 | $9.47B | 20.3 | +66.3% | 81 |
 | $4.43B | 13.4 | +7.5% | 76 |
 | $90.03B | 30.8 | +0.2% | 70 |
US stock research
About Hawkins, Inc. (HWKN) stock
Hawkins, Inc. tracked in the US core universe. HWKN was +3.1% in the latest available session at $132.02. Its reported market value was $2.67B with a trailing P/E of 33.1. Latest reported revenue was $1.11B, changing +9.3% year over year, with $80.63M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $132.02
- Day change
- +3.1%
- Market cap
- $2.67B
- P/E (TTM)
- 33.1
- Revenue growth
- +9.3%
- Industry
- Specialty Chemicals